Imkeldi is supplied as a strawberry-flavored oral solution in a 140mL child resistant tamper-evident bottle. The Food and Drug Administration (FDA) has approved Imkeldi, an oral solution ...

The FDA has approved imatinib oral solution (Imkeldi) for the treatment of certain forms of leukemia and other cancers. This is the first oral liquid form of imatinib for the treatment of select ...

Please provide your email address to receive an email when new articles are posted on . Imatinib interruption resulted in shorter median OS. Interruption also appeared linked to rapid progression ...

For comparison, we also tested the Glide XP docking from the Schrödinger suite and DiffDock to dock the two known type II inhibitors (imatinib and ponatinib) against DDR1 AF2 structure and the 15 ...

We hope to add results when they are available. This trial is for people with gastrointestinal stromal tumour (GIST) who have had surgery and taken imatinib for 3 years. Cancer Research UK supports ...

Painful crises in sickle cell disease or sickle cell anemia could potentially be treated using imatinib as a therapeutic option, a small study found. Painful crises that occur in patients with ...

ATS 2022, San Francisco, CA – Patients with severe COVID-19 who were given imatinib had lower mortality rates at 90-day follow-up, according to research published at the ATS 2022 international ...

Patients with severe COVID-19 who were given imatinib had lower mortality rates at 90-day follow-up, according to research published at the ATS 2022 international conference. The study ...